ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1645

Clinical Features of Axial Spondyloarthritis Patients Diagnosed in Secondary Versus a Tertiary Hospital

Ann-Sophie De Craemer1,2, Thomas Renson1,2, Philippe Carron1,2, Peggy Jacques1,2, Rik Joos1,3,4, Jan Lenaerts5,6, Lieve Gyselbrecht7, Filip van Den Bosch1,2 and Dirk Elewaut1,2, 1Department of Rheumatology, Ghent University Hospital, Ghent, 9000, Belgium, 2VIB Inflammation Research Center, Ghent, 9000, Belgium, 3Department of Rheumatology, Antwerp University Hospital, Edegem, 2650, Belgium, 4Department of Rheumatology, ZNA Jan Palfijn, Merksen, 2170, Belgium, 5Reuma Institute Hasselt, Hasselt, 3500, Belgium, 6Department of Rheumatology, Leuven University Hospital, Leuven, 3000, Belgium, 7Department of Rheumatology, ASZ Aalst, Aalst, 9300, Belgium

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: axial spondyloarthritis, classification criteria and clinical practice

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Diagnosis of axial spondyloarthritis (axSpA) often relies on a positive MRI of the SI joints. However, pitfalls in interpretation of MRI images were recently acknowledged (1). Thus reader’s expertise might be a source of heterogeneity in patient populations diagnosed with non-radiographic axSpA. Therefore we compared clinical characteristics between axSpA patients diagnosed in general (secondary) hospitals (MRI evaluation by local experts) versus a university-affiliated (tertiary) hospital (MRI central reading by trained radiologists and rheumatologists). In all centers, patients were free to visit a rheumatologist of their choice without necessity for referral by a general practitioner.        

Methods:

Patients originate from the Be-Giant cohort, a nationwide observational registry of axSpA patients diagnosed by expert opinion. Included patients fulfill the Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axSpA (2) and are anti-TNF-α naïve prior to inclusion. Patient enrollment started in 2010 and 2012 at the outpatient clinic of 1 tertiary and 7 secondary centers respectively. An extensive patient description was performed at baseline, followed by a 6-monthly follow-up.

Results:

By June 2018, 223 axSpA patients were included. Demographic and clinical features are presented according to the diagnostic echelon (Table 1). The HLA B27 positivity rate was 52,9% and 74,6% in secondary versus tertiary centers (p = 0,013). The patient fraction fulfilling the imaging arm of the ASAS classification criteria was similar in both (89,9% vs. 85,3%, p = 0,418), but significantly more patients both fulfilled the imaging and the clinical arm in the tertiary versus secondary centers (64,5% vs. 38,2%, p = 0,004).

Conclusion:

Patients diagnosed with axSpA in secondary versus a tertiary hospital generally show similar demographic and clinical characteristics. For axSpA patients diagnosed in a tertiary center, fulfillment of both ASAS classification arms and HLA B27 positivity rate was significantly higher, indicating that rheumatologists in secondary hospitals seem to assign more value to MRI findings compared to HLA B27 status in the diagnostic process.     

1.         Varkas G, de Hooge M, Renson T, De Mits S, Carron P, Jacques P, et al. Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study. Rheumatology (Oxford). 2018;57(3):508-13.

2.         Rudwaleit M, Van Der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-83.

 

 

Secondary centers

(n = 34)

Tertiary center

(n = 189)

p-value

(α = 0.05)

Age at diagnosis (years) *

32,7 (7,19)

30,5 (9,32)

0,070

Male gender **

14 (41,2)

100 (52,9)

0,208

Caucasian ethnicity **

33 (97,1)

179 (94,7)

0,560

HLA B27 positivity **

18 (52,9)

141 (74,6)

0,013

Symptom duration at time of diagnosis (months) *

58,2 (68,54)

52,3 (67,55)

0,747

ASAS classification criteria:

 

 

 

fulfilling the imaging arm **

29 (85,3)

170 (89,9)

0,418

fulfilling the clinical arm **

18 (52,9)

141 (74,6)

0,010

fulfilling both the imaging and the clinical arm **

13 (38,2)

122 (64,5)

0,004

Family history of SpA (1st or 2nd degree relative) **

12 (35,3)

77 (40,7)

0,549

Peripheral manifestations:

 

 

 

Arthritis (history or current) **

5 (14,7)

34 (18,0)

0,643

Dactylitis (history or current) **

0 (0)

9 (4,8)

0,194

Enthesitis (history or current) **

4 (11,8)

18 (9,5)

0,687

Extra-articular manifestations:

 

 

 

Psoriasis (history or current)**

6 (17,6)

19 (10,1)

0,196

Inflammatory bowel disease (history or current) **

1 (2,9)

8 (4,2)

0,725

Acute anterior uveitis (history or current) **

4 (11,8)

28 (14,8)

0,640

Clinical measurements:

 

 

 

BMI (kg/m²) *

23,6 (3,63)

24,6 (4,16)

0,169

BASMI *

1,5 (1,52)

1,5 (1,40)

0,865

Maastricht Ankylosing Spondylitis Enthesitis Score + fascia plantaris (/15) *

1,7 (3,05)

0,9 (1,56)

0,397

Patient reported outcomes:

 

 

 

BASDAI (/100) *

42 (19,3)

42 (19,9)

0,956

BASFI (/100) *

26 (21,7)

27 (21,8)

0,785

HAQ (/60) *

4,7 (5,07)

4,8 (5,69)

0,826

Ankylosing Spondylitis Disease Activity Score – CRP *

2,43 (1,022)

2,57 (0,961)

0,405

Table 1: * Numbers indicate mean (SD). ** Numbers indicate absolute counts (%).   

 


Disclosure: A. S. De Craemer, None; T. Renson, None; P. Carron, None; P. Jacques, None; R. Joos, None; J. Lenaerts, None; L. Gyselbrecht, None; F. van Den Bosch, None; D. Elewaut, None.

To cite this abstract in AMA style:

De Craemer AS, Renson T, Carron P, Jacques P, Joos R, Lenaerts J, Gyselbrecht L, van Den Bosch F, Elewaut D. Clinical Features of Axial Spondyloarthritis Patients Diagnosed in Secondary Versus a Tertiary Hospital [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/clinical-features-of-axial-spondyloarthritis-patients-diagnosed-in-secondary-versus-a-tertiary-hospital/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-of-axial-spondyloarthritis-patients-diagnosed-in-secondary-versus-a-tertiary-hospital/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology